Does INOTERSEN Cause Mobility decreased? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Mobility decreased have been filed in association with INOTERSEN. This represents 2.7% of all adverse event reports for INOTERSEN.
46
Reports of Mobility decreased with INOTERSEN
2.7%
of all INOTERSEN reports
7
Deaths
31
Hospitalizations
How Dangerous Is Mobility decreased From INOTERSEN?
Of the 46 reports, 7 (15.2%) resulted in death, 31 (67.4%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INOTERSEN. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does INOTERSEN Cause?
Platelet count decreased (334)
Protein urine present (269)
Glomerular filtration rate decreased (264)
Urine protein/creatinine ratio increased (249)
Blood creatinine increased (214)
Fatigue (198)
Bacterial test positive (193)
Urine abnormality (184)
Nausea (152)
Malaise (145)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which INOTERSEN Alternatives Have Lower Mobility decreased Risk?
INOTERSEN vs INOTUZUMAB OZOGAMICIN
INOTERSEN vs INSULIN
INOTERSEN vs INSULIN ASPART
INOTERSEN vs INSULIN ASPART\INSULIN DEGLUDEC
INOTERSEN vs INSULIN BEEF